May 2017





No Image

New twist in fight over patent on cancer drug

New twist in fight over patent on cancer drug Mumbai: The fight for a patent on a steeply-priced wonder drug, Xtandi (enzalutamide) used in prostate cancer has taken an interesting turn, with a … View the…



No Image

How BRI Impacts Proof of Prior Invention

How BRI Impacts Proof of Prior Invention Intellectual Ventures v. Motorola (Fed. Cir. 2017) In a short opinion, the Federal Circuit has rejected a PTAB IPR determination finding IV’s patent invalid and has remanded for reconsideration…








No Image

TiVo Beats Comcast In Patent Dispute

TiVo Beats Comcast In Patent Dispute ( TIVO ) has won a patent case against Comcast Corp. … other things, that a violation of section 337 has occurred with respect to U.S. Patent Nos. View…



No Image

FDA Assails Amgen's Sensipar Exclusivity Suit

FDA Assails Amgen's Sensipar Exclusivity Suit The U.S. Food and Drug Administration on Wednesday assailed a new lawsuit from Amgen Inc. challenging denied exclusivity for blockbuster calcium-control drug Sensipar, calling the suit premature and arguing…